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Background. Understanding the mechanisms that control rates of disease progression in humans and other species is an
important area of research relevant to epidemiology and to translating studies in small laboratory animals to humans. Body
size and metabolic rate influence a great number of biological rates and times. We hypothesize that body size and metabolic
rate affect rates of pathogenesis, specifically the times between infection and first symptoms or death. Methods and
Principal Findings. We conducted a literature search to find estimates of the time from infection to first symptoms (tS) and to
death (tD) for five pathogens infecting a variety of bird and mammal hosts. A broad sampling of diseases (1 bacterial, 1 prion, 3
viruses) indicates that pathogenesis is controlled by the scaling of host metabolism. We find that the time for symptoms to
appear is a constant fraction of time to death in all but one disease. Our findings also predict that many population-level
attributes of disease dynamics are likely to be expressed as dimensionless quantities that are independent of host body size.
Conclusions and Significance. Our results show that much variability in host pathogenesis can be described by simple power
functions consistent with the scaling of host metabolic rate. Assessing how disease progression is controlled by geometric
relationships will be important for future research. To our knowledge this is the first study to report the allometric scaling of
host/pathogen interactions.
Citation: Cable JM, Enquist BJ, Moses ME (2007) The Allometry of Host-Pathogen Interactions. PLoS ONE 2(11): e1130. doi:10.1371/
journal.pone.0001130
INTRODUCTION
Most emerging infectious diseases that cause human epidemics (e.g.
HIV, Influenza, West Nile Virus, Ebola) evolved in other animal
hosts [1,2]. However, little theory exists that enables the translation
of our knowledge about pathogenesis, rates of evolution, vaccination
strategiesorepidemiologyinthesezoonoticdiseasestotheirbehavior
in human hosts. One important observation is that the rate
pathogens spread through populations appears to be influenced by
the rate of spread through individual hosts [3,4]. Therefore,
understanding the time-course of pathogenesis in an individual,
including the length of the latency and infection periods, could aid in
parameterization of epidemiological models. A comparative ap-
proach to studying disease progression in different animal hosts may
also elucidate how diseases affect human health.
Pathogenesis is a complex phenomenon that results from several
aspects of host-disease interactions [5]. There are four main
determinants of pathogenesis: (i) the interaction of the disease with
the target tissue, (ii) the ability of the infection to cause cell death
or cytopathology, (iii) the host immune response to infection, and
(iv) immunopathology (e.g, T-cell and antibody responses).
Although we know much about the physiological mechanisms
for each of these host-disease interactions, there is still no easy
answer for how pathogen infection ‘causes’ disease in a host [5].
Here we take a scaling approach to understand variation in the
pace of pathogenesis. Specifically, what controls the scaling of
pathogenesis times within and across diseases?
Here we focus on the role of host body size and metabolic rate in
influencing the scaling of pathogenesis. There is a rich literature
documenting how the body size of an animal influences its structure,
function, and life history [6–11]. The overwhelming importance of
body size has been eloquently summarized by George Bartholomew
who stated, ‘‘It is only a slight overstatement to say that the most
important attribute of an animal, both physiological and ecological-
ly, is its size. Size constrains virtually every aspect of structure and
function and strongly influences the nature of most inter- and
intraspecific interactions. Body mass is the most widely used
predictor of physiological rates.’’ [12]. However, little is known
about the influence of host body size on pathogenesis in the context
of the scaling of host-pathogen interactions. As we outline below, it is
reasonable to expect that host body size and metabolic rate must
constrain rates of pathogenesis.
The Metabolic Scaling Theory (MST) for
pathogenesis
Our hypothesis that host body size and ultimately host metabolic
rate constrains rates of pathogenesis is based on recent theoretical
developments for the scaling of biological rates and times [8,10,11].
Metabolic Scaling Theory (MST) predicts that physiological times
and cellular metabolic rates are ultimately controlled by the scaling
of the geometry of fractal-like vascular networks. This work
secondarily hypothesizes that the scaling of physiological rates and
times are governed by quarter-power scaling exponents. Specifi-
cally, quarter-power exponents in biology are the result of natural
selection on vascular networks to minimize the scaling of internal
transport times while maximizing the scaling of resource exchange
surfaces (lung surface area, gut surface area etc). This work predicts
a fractal-like vascular network design that, when scaled with the
size of the organism in which it is contained, will lead to rates and
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progression are ultimately constrained by network geometry and
host metabolism, then pathogenesis will vary, or scale, with host
body mass raised to a 1/4 power.
A number of studies have pointed to the fundamental importance
of metabolism, or body size, in controlling the rates and timings of
biological phenomena [9–11,13]. This work has its roots in
fundamental work by Kleiber [7]. Kleiber showed that whole
organism metabolic rate, B, scaled allometrically (with an exponent
less than 1) so that B=B0?M
3/4. Many subsequent studies supported
this finding in a variety of taxa [6,9,14,15], although others have
questioned the generality of the 3/4 exponent [16,17]. If B!M
3/4
then the cellular or mass-specific metabolic rate,
B
M
,d e c r e a s e s
allometrically with body size as
B
M
!M{1=4 [[9 and refs
therein,][14]]. The theoretically predicted and empirically observed
M
21/4 decease in metabolism appears regulated by a similar M
21/4
decrease in the amount of metabolic machinery. For example, the
membrane surface area and number of mitochondria, concentration
of ATP, number of cytochrome oxidase molecules, etc, all decrease
with increasing host body size to the approximate 21/4 power
[13,18–20]. Since all other cellular rates are constrained by the
metabolic rate of the cell, then the theory suggests that the rate of
DNA synthesis, protein synthesis, immune response, and cellular
turnover should also scale with M
21/4, and biological times, T,
should scale as theinverse ofthoserates, oras M
1/4[9]. Cellular rates
are relevant to pathogenesis because they control the rates at which
pathogens enter a host, replicate, spread through the host body and
cause disease.
Thus, according to the MST the pace of host-pathogen
interactions (e.g. pathogenesis) is set by rate of host metabolism.
The host metabolic rate influences pathogenesis by (i) constraining
the rate of growth of pathogens that rely on host metabolic
machinery (in much the same way as it limits the rate of growth of
host [21]) as well as (ii) influencing the rate of the immune response
of the host. In fact, cellular-mediated immunity appears to scale
with body size and associated life history traits [22]. Thus, host
metabolic rate influences the rate of pathogenesis since the ability
of a pathogen to invade and replicate within a host may be driven
by physiological rates and times of the host. Specifically, the times
associated with pathogenesis are related to M by t=c?M
b where c is
a constant particular to the time of interest, and b=1/4. Since
mass specific metabolism (B/M), scales as M
21/4, then we expect
rates of pathogenesis to scale with M
21/4and times associated with
pathogenesis to scale with M
1/4. We assess these functional
predictions with empirical data compiled from the literature. As
far as we know, this is the first study to examine how pathogenesis
varies as a function of host body size.
For a sampling of pathogens (one bacteria, three viruses, and
one prion), we show how variation in host size, M, influences
variation in the timing of pathogenesis. We focus on the time from
inoculation to first symptoms (tS) and to death (tD). The MST
predicts that both tS and tD will scale as the 1/4 power of




The terms, c1 and c2, in Eqs. 1 and 2 are scaling constants. The
simplest model would have the values of c1 and c2 independent of
M. Nevertheless, differences in their values reflect important
interactions between host and pathogen and may be different for
the pathogenesis of different diseases. We can combine Eqs. 1 and






The values of c1 and c2 likely reflect the timing of the host immune
response and additional physiological responses to infection. These
values may also be influenced by host body temperature, taxonomic




the ratio between time to death and time to symptoms. Variability in
this quotient between diseases would indicate proportional differ-
ences in the timing of between time until first symptom and time
until death between diseases. However, similarity in this quotient
between diseases would indicate generality in the proportional rates
between diseases. Since our study is limited to homeotherms in
similar taxonomic groups (mammals, and in the case of West Nile
Virus, birds), within a particular pathogen, we expect c1 and c2 to be
constant. If correct, then Eqs. 2–3 predict the timing of pathogenesis
should be fundamentally set by host metabolism. However, for
agiven disease,the pacesofvariouspathologicaleventsarepredicted
to be directly proportional, or isometric, to one another, so that
tS!tD. Further, the ratio of pathogenesis times should be in-





We use MST to predict that tS and tD scale with M
1/4. We contrast
these predictions with the null hypothesis that tS and tD are
independent of host body size (M). However, it is important to
note alternative hypotheses that relate tS and tD to M. For example,
symptoms or death may occur when some fraction of the number
of cells in the organism has been infected. Since the number of
cells is isometric with body mass [23], then tS and tD would be
predicted to be linear with M. Alternatively the relationship
between host mass and the timing of pathogenesis could be
a geometric relationship controlled by body length or internal
transport distances (i.e., in rabies or PRV, the distance the
pathogen must travel from the site of infection to the brain). In
simple Euclidean geometry, body length scales with body mass to
the 1/3 power [e.g., 24]. The fractal network geometry of MST
predicts that internal transport lengths show the same scaling as
biological times; both scale with M
1/4. Here we specifically test the
MST 1/4 power predictions, but we note which of the alternative
predictions (M
1, and M
1/3) are consistent with the data.
RESULTS
We assessed the MST hypothesis by assembling data on the scaling
of the timings of pathogenesis for five diseases. We collected data
on tS and tD and M for a variety of pathogens infecting mammalian
and bird species. Each of these diseases infect mammalian hosts
that range in body size, M, by several orders of magnitude (e.g.,
Table 1). For the most part, empirical data support predictions
made by the MST. In all five pathogens, there is a significant
positive correlation between the timing of pathogenesis and M
(Figure 1). For PRV, the scaling slope was positive, but was
significantly lower than the predicted value of 1/4. For the
remaining diseases, all slopes overlapped the predicted value of 1/
4 (Table 1). The relationship between tS and tD had a slope close to
1 (Figure 2). Our results were not consistent with the alternative
hypothesis that the timing of pathogenesis and M are isometric
(slope of 1). However, the following diseases were consistent with
Allometry and Disease
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to the 1/3: anthrax (tS, tD), rabies (tS, tD), TSE (tS) (Table 1).
There was variation in the scaling constants for each disease
(Table 1), as exemplified inFigure 1 where the scaling slope was very
similar but the intercepts (which gives c1) differed. The values of c1
and c2 ranged from 0.64 to 4.4. For example, for PRV, the time until
death, tD, was 2.8 days for a 21 g mammal, whereas in Rabies the
same size mammal was characterized by tD of 8.6 days. However,
there was much less variation in the ratio of
c1
c2
as shown in Figure 3,
where 86% of the values fell between 0.8–1.8 (Figure 3).
DISCUSSION
Our results are generally consistent with the MST, where the
timing of pathogenesis is controlled by host cellular metabolic rate.
That is, the progression of disease to symptoms and to death slows
as a function of M
1/4. Variation in tS and tD for each disease
appears to scale with host body size with exponents consistent with
the scaling of host metabolism. Observed relationships all scale
with exponents very close and often indistinguishable from the
predicted value of 1/4 (Figure 1).
As indexed by the fitted allometric intercepts, each disease
differs in the relative timing of tS and tD (i.e. host-pathogen
interactions differ in their value of c2 and possibly c1). A plot of tS
vs. tD across the diverse diseases studied reveals that the timing of
pathogenesis for each disease, remarkably, falls on the same
function that is approximately isometric (slope of 1) (Figure 2).
Such invariance indicates that the allometric value of the ratio
c1
c2
(see Eq. 3) is the same invariant quantity for each of the diseases
studied here. We also provide a histogram of
c1
c2
to show this ratio
typically has a mean value of 1.6 (standard deviation 0.80)
(Figure 3) and does not change systematically with M. This implies
a relationship, general among these diseases, whereby the time to
the first sign of infection is a constant proportion of the time to
death–a constant that is conserved across each of the diseases
Figure 1. Time (days) from inoculation to (a) death and (b) 1
st symptom versus mammalian body mass for Pseudorabies virus (PRV), Anthrax,
Rabies, West Nile Virus (WNV), and Transmissible Spongiform Encephalopathy (TSE).
doi:10.1371/journal.pone.0001130.g001
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c1
c2
shows a long tail (Figure 3);
perhaps these outliers are influenced by host immune response,
medial care in humans, or specific host-pathogen interactions.
Further investigation of pathogenesis in these mammals (cat,
human, camelid, and elephant) may shed more light on
mechanisms of allometric pathogenesis. It would also be in-
teresting to understand how variation in evolutionary forces on
these organisms affects host-pathogen interactions.
The scaling for PRV appears to not follow the predicted pattern
of timing of pathogenesis as strongly as the other four diseases.
PRV has a positive trend in the scaling relationship with significant
slopes but they are more-shallow than predicted. It is unclear why
PRV differs from the other diseases. Nevertheless, our model
provides a baseline to begin to explore why PRV may deviate from
the exact predictions of the MST. Explaining the causes of
variation around the regression lines in Figures 1 is a natural, and
we believe, fruitful next step to this analysis.
Our results also indicate that disease allometry across diverse
populations may be characterized by invariant dimensionless
quantities. Because mammalian life-span and population doubling
time scale as tLS=c3?M
1/4 and tP=c4?M
1/4, respectively [9], where
c3 and c4 are allometric constants with units of time, and if
tD=c2?M























Note, both X1 and X2 are dimensionless ratios invariant of
mammalian body size. Thus, remarkably, across all mammals the
fraction of adult lifespan or population cycle influenced by a given
disease is an approximately constant value independent of
mammalian body size.
We have shown that the scaling of times associated with
pathogenesis is consistent with the scaling of host metabolic rate,
supporting the MST. We have suggested that such scaling could
result if pathogen growth and replication are directly limited by the
cellular metabolic rates of the hosts. We are not aware of any other
model(s) that would lead to functional relationships of tS and tD that
are power-functions of body mass with exponents near 1/4.
Figure 2. Time (days) from inoculation to death (tD) versus time from inoculation to 1
st symptom (tS) for Pseudorabies Virus (PRV), Anthrax, and
Rabies for a large range of mammalian body sizes, plotted with the 1:1 line.
doi:10.1371/journal.pone.0001130.g002
Table 1. Slope and intercept (2.5%, 97.5% values), R
2, p values,
and body mass range (kg) for tS (time from inoculation to 1st




2 p Mass Range
tS
Anthrax 0.18 (0.11, 0.32)
ab 0.17 (0, 0.33)
c 0.90 0.013 0.55–442
PRV 0.12 (0.07, 0.21)
a 0.43 (0.30, 0.55)
c 0.33 0.051 0.022–442
Rabies 0.33 (0.21, 0.54)
b 0.93 (0.57, 1.29) 0.28 0.037 0.022–4545
TSE 0.22 (0.15, 0.32)
ab 2.35 (2.20, 2.52) 0.76 0.001 0.015–500
tD
Anthrax 0.22 (0.12, 0.39)
a 0.29 (0.08, 0.51)
c 0.62 0.021 0.022–442
PRV 0.11(0.08, 0.16)
b 0.59 (0.53, 0.66)
d 0.69 ,0.001 0.022–450
Rabies 0.26 (0.15, 0.44)
a 1.2 (0.84, 1.5)
e 0.35 0.041 0.022–4545
WNV 0.17 (0.10, 0.28)
ab 0.95 (0.84, 1.1)
e 0.51 0.014 0.02–200
tS vs tD
Anthrax 1.17 (0.65, 2.12)
a 0.05 (20.26, 0.37)
b 0.88 0.018 0.55–442
PRV 0.83 (0.46, 1.48)
a 0.23 (20.06, 0.53)
b 0.34 0.058 0.022–442
Rabies 0.82 (0.63, 1.06)
a 0.34 (20.01, 0.68)
b 0.86 ,0.001 0.022–4545
*PRV: Pseudorabies Virus, TSE: Transmissible Spongiform Encephalopathy, WNV:
West Nile Virus
Significant p values (,0.05) denote slopes that differ from 0. Bolded slope
values do not differ from 0.25. Slope and intercept values that differ among
diseases (but within each time category) have different super-scripted letters.
































































































PLoS ONE | www.plosone.org 4 November 2007 | Issue 11 | e1130However, it is possible that the observed scaling could be an indirect
result of metabolic rate. For example, host immune and other
physiologicalresponsestopathogensmaycause theobserved scaling,
rather than the rate at which pathogens replicate, or the scaling may
represent some combination of factors. It is also possible that
pathogens may evolve latency periods in order to maximize their
fitness given the population dynamics of the host. Evidence of this is
seenintheevolutionoftSinTSE.Whenlaboratorymiceareinfected
with TSE from larger animals (sheep or cows), tS is initially several
times longer than after the infection has persisted in mouse
populations for several generations. This effect is known as the
‘species barrier’ (Gardash’yan 1976, Nonno and Trevitt 2006; in
supplementary material). Thus, when TSE is transmitted to a new,
smaller, species, it evolves a faster tS after just a few generations.
We would like to note that an extensive survey of the veterinary
and disease literature (see SupplementaryInformation)revealed only
five diseases that allowed for sufficient body size variation and with
enough reported values of pathogenesis times, and only three of
those gave both time to symptoms and time to death. In future
pathogenesis studies, we urge researchers to carefully report
associated pathogenesis times as this will greatly increase the range
of studies available for disease allometry, and greatly improve the
ability to discriminate between MST and other hypotheses, such as
the geometric hypothesis (scaling exponent of 1/3). While data were
available for a large range of mammal body sizes (see Table 1), data
were unavailable for animals at either extreme of the spectrum of
body masses, such as shrews and whales. MST makes theoretical
predictions for these animals. For example, in whales, experimental
infection with disease would be very difficult. Our model, however,
indicatesthatwewould expectpathogenesistimesforablue whaleto
be about 1.5 orders of magnitude longer than for a 1 kg mammal.
Ourresultssuggestthatacomparativeapproachtopathogenesisis
valuable, and that MST gives novel theoretical predictions for
understanding the pace and progression of disease. While there is
variation in the scaling relationships we show, there are clearly
systematic and allometric (slopes less than 1) relationships between
times of pathogenesis and body size. Our initial survey indicates that
the observed scaling exponents are consistent with the scaling of host
metabolic rate (MST). These results support the notion that the
scaling of metabolism fundamentally constrains rates of pathogen-
esis. Furthermore, our results have important implications for
epidemic models that often assume that the timing of and dynamics
of pathogenesis is independent of host body size, metabolism, or
pathogen transport times [3]. Our findings also suggest that a focus
on the fundamental role of how the scaling of host metabolism
influences thepaceofpathogenesiscould contribute to a mechanistic
understanding of pathogenesis, and in turn, a foundation for
predictive diagnostics, effective vaccination and therapy.
MATERIALS AND METHODS
Empirical Data
Data were gathered from an extensive literature search, the
references for which are supplied as supporting online material
(Text S1). The data incorporated four measures of host-pathogen
interactions including: tD, the time to death of the host from
inoculation with the pathogen (as indexed by either the time when
an individual animal died or the time at which 50% of the
experimental population died from a lethal dose or LD50); tS, the
time to first sign of infection from inoculation; and [P] the
concentration of pathogen particles injected during the reported
study (Table S1). Data stem from in situ experiments. Values of
pathogenesis times were reported in the original citations listed in
the supplementary information (Text S1). In general, each study
reported the observed time of first infection, sign of infection, and
death. Studies reported values for a single individual or for
a population. When data were assembled from population
observations the recorded times were average values.
Our literature survey revealed three diseases for which tD, and tS
were measured for a sufficient number of mammalian hosts that
span a sufficiently wide range of M to test the value of the scaling
exponent. Note that both tD and tS were not reported for every
animal (Table S1). The number of animals for each disease:
Pseudorabies Virus or PRV (Herpesvirus suis) n=16; Anthrax
bacteria (Bacillus anthracis) n=11; Rabies virus (Lyssavirus sp.)
Figure 3. The frequency of
c1
c2
values for Pseudorabies Virus, Rabies, and Anthrax across a large range of mammalian body sizes.
doi:10.1371/journal.pone.0001130.g003
Allometry and Disease
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and West Nile Virus (flavivirus) n=11. Each is extremely lethal in
its host and exhibits characteristic symptoms. Mammalian hosts
differed in M by approximately 5 orders of magnitude (ranging
from mice to horses and bears, Table S1). We found data on tD
(but not tS) for West Nile Virus (WNV) and tS (but not tD)
Transmissible Spongiform Encephalopathy (TSE), diseases such as
scrapie and mad cow disease that are caused by a prion pathogen.
Analysis
We tested Eqs. 1 and 2 using reduced major axis (RMA)
regression (analysis of covariance, ANCOVA) on log transformed
data [SMATR, 25]. Each data point represents tS or tD and M for
a particular pathogen in a particular host species. We treated each
disease as a separate regression and estimated c1 and c2 for each
disease. We also tested whether the ratio,
c1
c2
, was constant across
all pathogens by plotting log c1 vs log c2 and testing whether the
slope of the RMA regression equals 1, and the group slope of
PRV, Anthrax, and Rabies do not differ from 1 (p=0.426) [26].
Since such methods do not necessarily indicate how much
variation there is in that ratio [27] following Savage et al. (2006)
[28] we further plot
c1
c2





We did not incorporate phylogenetic corrections [29] in this
analysis because it is not feasible for the limited number of animal
hosts for which we have data. Nor did we attempt to look at the
scaling of pathogenesis across growing individuals of the same
species, again due to lack of data. If more data become available, we
encourage such analysis in future tests of the MST for pathogenesis.
SUPPORTING INFORMATION
Table S1 The species, mass (kg), and time data collected from
the literature. These data are from the literature listed in the
supplementary material Text S1 and used in analyses across the
five diseases; tD is the time to death from inoculation and tS is
time to first symptom from inoculation (d). The five diseases are as
follows: A=Anthrax, P=Pseudorabies Virus, R=Rabies,
W=West Nile Virus, T=Transmissible Spongiform Encephalop-
athy. Where multiple masses are listed, the value used with each
disease is noted with the letter of the disease (A, P, R, W, or T).
Found at: doi:10.1371/journal.pone.0001130.s001 (0.11 MB
DOC)
Text S1 Literature for disease data.
Found at: doi:10.1371/journal.pone.0001130.s002 (0.05 MB
DOC)
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